Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2026 10:00 ET | Source: Precedence Research

Middle East Packaging Machinery Market Set for Robust Growth, Projected to Reach USD 3.63 Billion by 2035

Ottawa, Feb. 27, 2026 (GLOBE NEWSWIRE) -- The global Middle East packaging machinery market stood at USD 1.9 billion in 2025 and is projected to reach USD 3.63 billion by 2035. Request Research...
February 27, 2026 09:00 ET | Source: Precedence Research

PCR-Rich Glass Container Market Set to Double by 2035, Driven by Growth in Asia Pacific and Premium Packaging Segments

Ottawa, Feb. 27, 2026 (GLOBE NEWSWIRE) -- The global PCR-rich glass container market size stood at USD 10.5 billion in 2025 and is projected to reach USD 21.04 billion by 2035. Request Research...
February 27, 2026 07:03 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment

Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment If approved, Dupixent would be the first...
February 27, 2026 07:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment

If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a...
February 27, 2026 05:55 ET | Source: Sanofi Winthrop Industrie

Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness

A new therapy, given as a single dose of three tablets, could offer a simpler alternative to longer, more complex regimens for sleeping sickness.
February 26, 2026 16:15 ET | Source: Alta Equipment Group

Alta Equipment Group Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Adjusted EBITDA Guidance for 2026

Fourth Quarter Financial Highlights: (comparisons are year over year) Total revenues increased 2.2% year over year to $509.1 millionConstruction and Material Handling revenues of $328.6 million and...
February 26, 2026 16:06 ET | Source: SoundHound AI

SoundHound AI Reports Record Annual Revenue of $169 Million, Up Nearly 100%, Forecasts Strong Growth

SoundHound AI Reports Record Annual Revenue of $169 Million, Up Nearly 100%, Forecasts Strong Growth
February 26, 2026 16:05 ET | Source: PureCycle Technologies

PureCycle Technologies Reports Fourth Quarter Fiscal Year 2025 Results & Corporate Update

PureCycle achieved record 7.5 million pounds of PureFive® production in Q4, appointed Donald Carpenter as CFO and progresses Gen-2 designs.
February 26, 2026 08:30 ET | Source: Where Food Comes From

Where Food Comes From, Inc. Reports 2025 Financial Results

Full Year Highlights – 2025 vs. 2024 Verification and certification revenue: $20.1M vs. $20.6MProduct sales: $3.6M vs. $3.8MTotal revenue: $24.9M vs. $25.7MNet income: $1.5M vs. $2.1MDiluted EPS:...
February 26, 2026 08:30 ET | Source: RenovoRx, Inc.

RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting

MOUNTAIN VIEW, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and...